blood clot - Health Xplore

Thursday, 8 October 2026

Response Research to Emerging Infectious Diseases Inform

March 26, 2024

Skin Type Before Choosing Skin Care Products

March 26, 2024

Using Lemon on Your Face & Ways to

March 26, 2024

Most Common Exercise Machines at the Gym

March 26, 2024

Contact Info

E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com

Tag: blood clot

CeleCor’s Investigational Heart Attack Drug Zalunfiban Moves to FDA Review

News

US FDA Accepts CeleCor’s NDA for Heart Attack Drug Zalunfiban

CeleCor’s Zalunfiban is a subcutaneously injected inhibitor of the platelet glycoprotein (GP) IIb/IIIa receptor designed for rapid pre-hospital treatment of STEMI heart attacks.

imphoenix82
October 1, 2026
0 Comments
415 Views

About Us

HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.

Email: support@healthxploreindia.com

Contact: +91 9354115542

Response Research to Emerging Infectious Diseases Inform

Skin Type Before Choosing Skin Care Products

Using Lemon on Your Face & Ways to

Most Common Exercise Machines at the Gym

Contact Info

Tag: blood clot

US FDA Accepts CeleCor’s NDA for Heart Attack Drug Zalunfiban

Genetic Testing Detects Rare Tay-Sachs Disease: Why Prenatal.

Charnock Hospitals, Philips Partner to Build Connected Healthcare.

Pfizer’s TUKYSA Approved for Frontline Maintenance in HER2+.

Glenmark Launches Adapalene Gel 0.1% in New Pump.

About Us

Quick Link

Top Categories

Top Posts

Laser Treatments for Anti-aging: Types, Benefits,

Lilly’s Retatrutide Shows Powerful Weight Loss

National Registry for Implantable Medical Devices: